SCHEMBL22984494

SCHEMBL22984494

CCc1ccc2c(C)c(C)[nH]c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.58
AHR P35869 1/20 0.48
MAPT P10636 4/20 0.47
HCRTR1 O43613 1/20 0.44
DAO P14920 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
THRB P10828 1/20 0.39
HPGD P15428 1/20 0.39
EGFR P00533 1/20 0.38
PTGS2 P35354 1/20 0.38
CDK1 P06493 1/20 0.37
CDK2 P24941 1/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PTGES O14684 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAOA P21397 1/20 0.36
DYRK1A Q13627 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5023941 0.85 MAPT (0.57) KIF11AHRMAPTHCRTR1KDM4E
SCHEMBL278605 0.81 KIF11 (0.81) KIF11AHRDAOKDM4EALDH1A1
SCHEMBL29864765 0.81 KIF11 (0.81) KIF11AHRDAOKDM4EALDH1A1
SCHEMBL27532886 0.78 KIF11 (0.50) KIF11MAPTDAOKDM4EALDH1A1
SCHEMBL6009663 0.77 KIF11 (0.68) KIF11MAPTDAOKDM4EALDH1A1
SCHEMBL20611958 0.75 AHR (0.56) KIF11AHRMAPTKDM4EALDH1A1
SCHEMBL17226000 0.74 KIF11 (0.64) KIF11AHRMAPTDAOKDM4E
SCHEMBL9307979 0.74 KDM4E (0.59) KIF11MAPTDAOKDM4EALDH1A1
SCHEMBL27410225 0.74 DAO (0.49) KIF11MAPTDAOKDM4EALDH1A1
SCHEMBL278610 0.73 KIF11 (1.00) KIF11AHRMAPTHCRTR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10918735-B2 Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10918735-B2 Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment IDO1, IDO2, INMT KIF11 1094/4885AHR 98/4885MAPT 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.